title: NMR-based metabolomic analysis of the molecular pathogenesis of therapy-related myelodysplasia/acute myeloid leukemia.
abstract: Hematopoietic stem cell transplantation is the oldest and most successful form of stem cell therapy. High dose therapy (HDT) followed by hematopoietic stem cell transplantation allows physicians to administer increased amounts of chemotherapy and/or radiation while minimizing negative side effects such as damage to blood-producing bone marrow cells. Although HDT is successful in treating a wide range of cancers, it leads to lethal therapy-related myelodysplasia syndrome or acute myeloid leukemia (t-MDS/AML) in 5--10% of patients undergoing autologous hematopoietic cell transplantation for Hodgkin lymphoma and non-Hodgkin lymphoma. In this study, we carried out metabolomic analysis of peripheral blood stem cell samples collected in a cohort of patients before hematopoietic cell transplantation to gain insights into the molecular and cellular pathogenesis of t-MDS. Nonparametric tests and multivariate analyses were used to compare the metabolite concentrations in samples from patients that developed t-MDS within 5 years of transplantation and the patients that did not. The results suggest that the development of t-MDS is associated with dysfunctions in cellular metabolic pathways. The top canonical pathways suggested by the metabolomic analysis include alanine and aspartate metabolism, glyoxylate and dicarboxylate metabolism, phenylalanine metabolism, citrate acid cycle, and aminoacyl-t-RNA biosynthesis. Dysfunctions in these pathways indicate mitochondrial dysfunction that would result in decreased ability to detoxify reactive oxygen species generated by chemo and radiation therapy, therefore leading to cancer-causing mutations. These observations suggest predisposing factors for the development of t-MDS.
authors.affiliation: Department of Molecular Medicine, Beckman Research Institute of the City of Hope, Duarte, California 91010, USA.
authors.forename: Kristin E
authors.initials: KE
authors.lastname: Cano
authors.forename: Liang
authors.initials: L
authors.lastname: Li
authors.forename: Smita
authors.initials: S
authors.lastname: Bhatia
authors.forename: Ravi
authors.initials: R
authors.lastname: Bhatia
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Forman
authors.forename: Yuan
authors.initials: Y
authors.lastname: Chen
mesh_terms: D000293:Adolescent; D000328:Adult; D053687:Adult Stem Cells / Q000378:metabolism; D000368:Aged; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006689:Hodgkin Disease / Q000378:metabolism / Q000628:therapy; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions; D015470:Leukemia, Myeloid, Acute / Q000209:etiology / Q000378:metabolism*; D008228:Lymphoma, Non-Hodgkin / Q000378:metabolism / Q000628:therapy; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D053858:Metabolic Networks and Pathways; D055442:Metabolome; D008875:Middle Aged; D015999:Multivariate Analysis; D009190:Myelodysplastic Syndromes / Q000209:etiology / Q000378:metabolism*; D016609:Neoplasms, Second Primary / Q000209:etiology / Q000378:metabolism*; D025341:Principal Component Analysis; D055815:Young Adult